Closing
date: 27 Oct 2015
date: 27 Oct 2015
Founded
in 2002 by President William J. Clinton, the Clinton Health Access Initiative
(CHAI) works to broaden access to life-saving treatment for HIV/AIDS,
tuberculosis and malaria patients in the poorest parts of the world. As part of
this mission, CHAI’s “Access Programs” approach global public health challenges
with market-based strategies, using simultaneous engagement on both the supply
and demand sides of the market. On the supply side, CH
in 2002 by President William J. Clinton, the Clinton Health Access Initiative
(CHAI) works to broaden access to life-saving treatment for HIV/AIDS,
tuberculosis and malaria patients in the poorest parts of the world. As part of
this mission, CHAI’s “Access Programs” approach global public health challenges
with market-based strategies, using simultaneous engagement on both the supply
and demand sides of the market. On the supply side, CH
AI engages with suppliers
of essential drugs and diagnostics to improve access to products by lowering
prices, accelerating new products to market, and sharing market intelligence.
On the demand side, CHAI organizes and consolidates demand for health
commodities by helping governments to scale up treatment programs, mobilize new
resources, improve procurement processes, and enhance local human resource
capacity. Working with over 30 governments and other partners, CHAI is focused
on large-scale impact on many of the largest barriers to effective treatment
and care.
The
Laboratory Services Team (LST) is a key source of support for Ministries of
Health and CHAI’s country teams, and works to address barriers to access and
foster a healthy competitive marketplace for essential diagnostic testing. LST
plays the lead role in coordinating work globally on access to diagnostics,
working closely with diagnostics manufacturers, governments, and multilateral
organizations to lower prices, increase access to testing, and accelerate the
entry and uptake of new innovative products.
Laboratory Services Team (LST) is a key source of support for Ministries of
Health and CHAI’s country teams, and works to address barriers to access and
foster a healthy competitive marketplace for essential diagnostic testing. LST
plays the lead role in coordinating work globally on access to diagnostics,
working closely with diagnostics manufacturers, governments, and multilateral
organizations to lower prices, increase access to testing, and accelerate the
entry and uptake of new innovative products.
Recent
news about CHAI’s work on access:
news about CHAI’s work on access:
HIV/AIDS
PBS,
October 2011:
October 2011:
CHAI
press release, May 2011:
press release, May 2011:
New
York Times, May 2011:
York Times, May 2011:
Malaria
Wall
Street Journal, July 2008:
Street Journal, July 2008:
The
Country Support Manager (CSM) will work with LST to ensure the rapid scale-up
and effective management of high-quality diagnostics for high burden diseases,
focusing primarily on diagnostics for patients with HIV and TB. The CSM will
work with Ministries of Health and CHAI country teams across multiple focal
countries, helping to optimize policies and processes, expand access to high
quality diagnostics, ensure that countries have adopted best practices in
planning and implementation of testing programs, and support forecasting and
procurement of essential diagnostic products. The CSM will also provide support
in the quantification and mapping of funding needs against available resources,
helping the government to identify funding gaps and design interventions and
scale up plans in consideration of current resources.
Country Support Manager (CSM) will work with LST to ensure the rapid scale-up
and effective management of high-quality diagnostics for high burden diseases,
focusing primarily on diagnostics for patients with HIV and TB. The CSM will
work with Ministries of Health and CHAI country teams across multiple focal
countries, helping to optimize policies and processes, expand access to high
quality diagnostics, ensure that countries have adopted best practices in
planning and implementation of testing programs, and support forecasting and
procurement of essential diagnostic products. The CSM will also provide support
in the quantification and mapping of funding needs against available resources,
helping the government to identify funding gaps and design interventions and
scale up plans in consideration of current resources.
Historically,
the majority of diagnostic testing for HIV and TB has been conducted on
conventional, laboratory-based technologies using sample transportation systems
to expand access to testing to patients living in rural areas. However, access
to these products is limited in many countries, and Ministries of Health
require continued support to improve the efficiency of these technologies,
expand their reach, and introduce new types of essential tests. In addition,
several POC products for diagnosis, disease staging, and treatment monitoring
have recently become available or are in development, with the potential to
dramatically increase access to treatment, improve patient retention, and make
healthcare systems more efficient. These technologies need to be integrated
with existing conventional laboratory networks, with an appropriate balance
between centralized and decentralized testing.
the majority of diagnostic testing for HIV and TB has been conducted on
conventional, laboratory-based technologies using sample transportation systems
to expand access to testing to patients living in rural areas. However, access
to these products is limited in many countries, and Ministries of Health
require continued support to improve the efficiency of these technologies,
expand their reach, and introduce new types of essential tests. In addition,
several POC products for diagnosis, disease staging, and treatment monitoring
have recently become available or are in development, with the potential to
dramatically increase access to treatment, improve patient retention, and make
healthcare systems more efficient. These technologies need to be integrated
with existing conventional laboratory networks, with an appropriate balance
between centralized and decentralized testing.
The
CSM will support countries in the implementation of both conventional,
laboratory-based diagnostic products and new, innovative point-of-care (POC)
products that bring diagnostics out of the laboratory and closer to the
patient. In particular, The CSM will support countries in adopting the recently
published WHO 2013 guidelines, including the use of viral load (VL) for monitoring
patients on anti-retroviral therapy (ART), and developing strategies for
scaling up testing programs, which include HIV diagnosis, CD4 testing, Early
Infant Diagnosis (EID) and other opportunistic infections. In addition, the CSM
will assist countries with the evaluation, adoption and uptake of new POC
diagnostic products, which can reduce the burden of undergoing testing, and
improve access to essential tests, particularly in rural areas.
CSM will support countries in the implementation of both conventional,
laboratory-based diagnostic products and new, innovative point-of-care (POC)
products that bring diagnostics out of the laboratory and closer to the
patient. In particular, The CSM will support countries in adopting the recently
published WHO 2013 guidelines, including the use of viral load (VL) for monitoring
patients on anti-retroviral therapy (ART), and developing strategies for
scaling up testing programs, which include HIV diagnosis, CD4 testing, Early
Infant Diagnosis (EID) and other opportunistic infections. In addition, the CSM
will assist countries with the evaluation, adoption and uptake of new POC
diagnostic products, which can reduce the burden of undergoing testing, and
improve access to essential tests, particularly in rural areas.
The
CSM will also support LST in global negotiations with diagnostics manufacturers
to lower prices, and with the development of new procurement strategies such as
instrument rental deals to enable easier product switching. Finally, the CSM
will help develop LST’s market-shaping strategy for fostering competition in the
global diagnostics market. In doing so, the CSM will develop strong
relationships with various teams within CHAI, as well as Ministries of Health,
diagnostics manufacturers, and other external partners in beneficiary
countries.
CSM will also support LST in global negotiations with diagnostics manufacturers
to lower prices, and with the development of new procurement strategies such as
instrument rental deals to enable easier product switching. Finally, the CSM
will help develop LST’s market-shaping strategy for fostering competition in the
global diagnostics market. In doing so, the CSM will develop strong
relationships with various teams within CHAI, as well as Ministries of Health,
diagnostics manufacturers, and other external partners in beneficiary
countries.
We
are seeking a highly motivated individual with outstanding credentials,
qualitative and quantitative analytical abilities, and communication skills.
The CSM must be able to function independently and flexibly and have a strong
commitment to excellence. CHAI places great value on relevant personal
qualities: resourcefulness, responsibility, tenacity, independence, energy,
work ethic and emotional intelligence.
are seeking a highly motivated individual with outstanding credentials,
qualitative and quantitative analytical abilities, and communication skills.
The CSM must be able to function independently and flexibly and have a strong
commitment to excellence. CHAI places great value on relevant personal
qualities: resourcefulness, responsibility, tenacity, independence, energy,
work ethic and emotional intelligence.
This
is a challenging but rewarding role, which will have direct and near-term
impact on thousands of patients in need of life-saving health services. The
role will be based in Rwanda with up to 50% travel in the region.
is a challenging but rewarding role, which will have direct and near-term
impact on thousands of patients in need of life-saving health services. The
role will be based in Rwanda with up to 50% travel in the region.
Responsibilities:
- Serve
as a key advisor to Ministries of Health, CHAI country teams, and
in-country and global partners on the expansion of access to diagnostic
testing, and the adoption of new diagnostic products and their integration
into existing laboratory networks - Manage
and coordinate diagnostics projects across multiple CHAI focal countries,
with multiple work streams in each country - Act
as the focal point to manage the relationship between LST and CHAI country
teams, including country team leadership - Share
best practices across country program to ensure knowledge is shared on the
strategies, tools and experiences of all programs - Support
countries in the adoption of the recently published WHO 2013 guidelines - Support
countries in the development of strategic and implementation plans for HIV
diagnosis in adults and children, including EID, CD4 and VL testing. - Support
the adoption of current and new HIV and TB diagnostic products and their
integration into existing lab networks - Assist
Ministries of Health to build capacity to perform technical evaluations to
drive regulatory approvals and ensure that new technologies perform
accurately, conduct operational pilots to demonstrate the cost
effectiveness and impact of new products on patient outcomes, and assist
with analysis and writing of evaluation reports - Develop
and share deployment models and strategies for how to maximize the impact
of existing and new diagnostic technologies - Prepare
impact analysis and build tools (forecasting, budgeting, work plans, etc.)
to support countries’ activities - Assist
Ministries of Health in the development of testing policies and national
implementation plans, and the creation of operational systems to support
the wide-scale implementation of new and existing diagnostic products,
such as training, quality assurance, and data management - Work
with CHAI country teams, governments, and partners to identify funding for
increased investment in new diagnostic products - Design
and implement monitoring and evaluation (M&E) systems to measure the
impact of new and existing technologies and assess progress against
project goals - Assist
LST to manage global supplier relationships through product demand
forecasting, market analysis, sharing of market intelligence, and
supporting price negotiations - Provide
remote and in-country technical assistance to CHAI country teams and
governments in support of work streams related to diagnostics - Minimum
qualifications: Bachelor’s degree plus 4-6 years work experience - Fluency
in both written and spoken French - Excellent
written and verbal communication skills, including the ability to prepare
and deliver compelling presentations and work on complex analyses - A
high degree of self-confidence and the ability to work effectively at all
levels of an organization – with fellow team members, and senior
executives from Ministries of Health and partner organizations - Strong
analytical, problem solving, and quantitative skills, and a commitment to
improvement and creative thinking with a capacity to critically assess
prior achievements and develop stronger solutions and processes - Ability
to think strategically, handle ambiguity and work in a fast-paced,
limited-structure, multicultural environment - Ability
to learn on the job quickly - Detail-oriented
with strong organization skills - Ability
to manage multiple work streams simultaneously and work independently - Available
for up to 50% travel - High
level of proficiency in Microsoft Excel, PowerPoint and Word
Pluses:
- Previous
CHAI experience - Policy
and program management experience - Experience
supporting governments in implementing health systems in resource-limited
settings - Experience
working in management consulting, investment banking, or similar
environment - Experience
living or working abroad, particularly in developing countries - Demonstrated
success in training, coaching and supporting fellow team members and
partners at all levels of an organization to build capacity in a
sustainable manner - Familiarity
with global health issues, particularly HIV/AIDS and TB
PI91937421